CEP-40783可抑制TAM受体和c-MET的磷酸化。在体外,这种对TAM和c-MET活化的抑制伴随下游MAPK和PI3K信号通路的下降,以及细胞活力的降低。在TAM表达细胞中,RXDX-106在亚纳摩尔浓度下完全抑制细胞增殖和活力。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | CEP-40783 is a robust, selective, and orally bioavailable antagonist of AXL and c-Met, exhibiting IC50 values of 7 nM and 12 nM, respectively. In cells transfected with AXL, such as 293GT, CEP-40783's activity is enhanced 27 times more than that of the recombinant enzyme, with an IC50 of 0.26 nM. Additionally, CEP-40783's efficacy against c-Met is pronounced in GTL-16 cells, with an IC50 of 6 nM. This heightened activity in cellular environments may be due to CEP-40783's prolonged binding to AXL and c-Met, aligning with a Type II mechanism. Furthermore, CEP-40783 is highly selective within the kinome, inhibiting over 90% of 298 kinases at a concentration of 1 µM, as indicated by an S90 value of 0.04[1]. |
| Concentration | Treated Time | Description | References | |
| Ba/F3 cells | 100 nM | 72 hours | Screening for drugs that inhibit MET D1228A/Y secondary mutations, CEP-40783 showed inhibitory effects | J Hematol Oncol. 2022 Jun 11;15(1):79. |
| Calu1 | 5 and 10 μM | 72h | Evaluate the effect of RXDX106 on cell viability | Mol Cancer Res. 2022 Apr 1;20(4):542-555. |
| Calu1 | 1 μM | 4 hours | Evaluate the effect of RXDX106 on global phosphoproteins | Mol Cancer Res. 2022 Apr 1;20(4):542-555. |
| Calu1 | 100 nM | 30 min | Evaluate the inhibitory effect of RXDX106 on AXL phosphorylation | Mol Cancer Res. 2022 Apr 1;20(4):542-555. |
| H1299 | 5 and 10 μM | 72h | Evaluate the effect of RXDX106 on cell viability | Mol Cancer Res. 2022 Apr 1;20(4):542-555. |
| H1299 | 1 μM | 4 hours | Evaluate the effect of RXDX106 on global phosphoproteins | Mol Cancer Res. 2022 Apr 1;20(4):542-555. |
| H1299 | 100 nM | 30 min | Evaluate the inhibitory effect of RXDX106 on AXL phosphorylation | Mol Cancer Res. 2022 Apr 1;20(4):542-555. |
| Animal study | CEP-40783 demonstrates a dose-responsive and temporal inhibition of AXL phosphorylation in NCI-H1299 NSCL xenografts, achieving 80% inhibition at a dosage of 0.3 mg/kg six hours after administration. At a dosage of 1 mg/kg, it maintains >90% inhibition from 6 to 24 hours post-dose, and a 10 mg/kg oral dose sustains complete AXL inhibition for up to 48 hours post-dosing[1]. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT03454243 | Advanced or Metastatic Solid T... 展开 >>umors 收起 << | Early Phase 1 | Terminated(Sponsor's decision) | - | United States, Texas ... 展开 >> START San Antonio, Texas, United States, 78229 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.70mL 0.34mL 0.17mL |
8.50mL 1.70mL 0.85mL |
16.99mL 3.40mL 1.70mL |
|
| CAS号 | 1437321-24-8 |
| 分子式 | C31H26F2N4O6 |
| 分子量 | 588.56 |
| SMILES Code | O=C(C1=CN(C(C)C)C(N(C2=CC=C(F)C=C2)C1=O)=O)NC3=CC=C(OC4=CC=NC5=CC(OC)=C(OC)C=C45)C(F)=C3 |
| MDL No. | MFCD28502441 |
| 别名 | RXDX-106 |
| 运输 | 蓝冰 |
| InChI Key | FKCWHHYUMFGOPY-UHFFFAOYSA-N |
| Pubchem ID | 71576419 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Sealed in dry,2-8°C |
| 溶解方案 |
DMSO: 2 mg/mL(3.4 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO |
沪公网安备 31011702889066号
沪ICP备2024050318号-1